Effect of personality type on pharmacodynamics through changing pharmacokinetics

Medical Hypotheses

Volumn 69, Issue 5, 2007, Pages 1131-1134

  Xu, Feng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CAPTOPRIL; CISAPRIDE; CYTOCHROME P450 2D6; DRUG METABOLIZING ENZYME; SILDENAFIL;

ANXIETY DISORDER; ARTICLE; CANCER; CHINESE; CLINICAL FEATURE; DEMOGRAPHY; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG METABOLISM; DYSPEPSIA; ERECTILE DYSFUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; INFECTION; MEDICAL LITERATURE; MEDICAL RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOLOGICAL ASPECT; SUICIDE ATTEMPT; TREATMENT RESPONSE;

CYTOCHROME P-450 CYP2D6; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, BIOLOGICAL; MODELS, PSYCHOLOGICAL; PERSONALITY; PHARMACOKINETICS;

EID: 34548747401     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.01.079     Document Type: Article

References (30)

1. Becquemont L., Verstuyft C., and Jaillon P. Pharmacogenetics and interindividual variability in drug response: cytochrome P-450 2C9 and coumarin anticoagulants. Bull Acad Natl Med 190 (2006) 37-49
2. Rapaport M.H., Pollack M., Wolkow R., Mardekian J., and Clary C. Is placebo response the same as drug response in panic disorder?. Am J Psychiat 157 (2000) 1014-1016
3. Stolk P., Ten Berg M.J., Hemels M.E., and Einarson T.R. Meta-analysis of placebo rates in major depressive disorder trials. Ann Pharmacother 37 (2003) 1891-1899
4. Singer C., Grossman I., Avidan N., Beckmann J.S., and Pe'er I. Trick or treat: the effect of placebo on the power of pharmacogenetic association studies. Hum Genomics 2 (2005) 28-38
5. Farabaugh A.H., Sonawalla S.B., Fava M., Pedrelli P., Papakostas G.I., Schwartz F., et al. Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysis. Hum Psychopharmacol 21 (2006) 221-225
6. Dobrilla G., and Scarpignato C. Placebo and placebo effect: their impact on the evaluation of drug response in patients. Dig Dis 12 (1994) 368-377
7. Khan A., Kolts R.L., Rapaport M.H., Krishnan K.R., Brodhead A.E., and Browns W.A. Magnitude of placebo response and drug-placebo differences across psychiatric disorders. Psychol Med 35 (2005) 743-749
8. Piercy M.A., Sramek J.J., Kurtz N.M., and Cutler N.R. Placebo response in anxiety disorders. Ann Pharmacother 30 (1996) 1013-1019
9. Flaten M.A., Simonsen T., and Olsen H. Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosom Med 61 (1999) 250-255
10. Xu F. Behavior and psychological risk factors influence the pharmacokinetics. Pharm JGD 9 (1999) 8-9
11. Jin Z.P. Effect of psychological risk factors on pharmacodynamics. Central South Pharm 1 (2003) 309-311
12. Bettencourt B.A., Talley A., Benjamin A.J., and Valentine J. Personality and aggressive behavior under provoking and neutral conditions: a meta-analytic review. Psychol Bull 132 (2006) 751-777
13. Cheng S.P. On students' depression and suicide and the interference of the crises. J Taishan Univ 28 (2006) 95-98
14. Yasunari K., Matsui T., Maeda K., Nakamura M., Watanabe T., and Kiriike N. Anxiety-induced plasma norepinephrine augmentation increases reactive oxygen species formation by monocytes in essential hypertension. Am J Hypertens 19 (2006) 573-578
15. Zhou G.P., and Wang R.K. Effect of Type A behavior on captopril pharmacokinetics. J Chin Clin Med 3 (2002) 94-95
16. El-Shafey H., Atteya A., Abu El-Magd S., Hassanein A., Fathy A., and Shamloul R. Tianeptine can be effective in men with depression and erectile dysfunction. J Sex Med 3 (2006) 910-917
17. Rosen R., Janssen E., Wiegel M., Bancroft J., Althof S., Wincze J., et al. Psychological and interpersonal correlates in men with erectile dysfunction and their partners: a pilot study of treatment outcome with sildenafil. J Sex Marital Ther 32 (2006) 215-234
18. Xu J., Zhou G.P., and Mi J. Type A behavior influences the sildenafil pharmacokinetics. Chin J Behav Med Sci 11 (2002) 664-665
19. Chen T.S., Lee Y.C., Chang F.Y., Wu H.C., and Lee S.D. Psychosocial distress is associated with abnormal gastric myoelectrical activity in patients with functional dyspepsia. Scand J Gastroenterol 41 (2006) 791-796
20. Dai J.Z. Psychological risk factors and rational drug use. Chin J Coal Ind Med 5 (2002) 5-6
21. Cai Z.F., Zhuang J.N., and Cha Z.K. Effects of anxiety and depression status on pharmacokinetics of cisapride tablet. Chin J Clin Pharmacol 21 (2005) 148-150
22. Eichelbaum M., Ingelman-Sundberg M., and Evans W.E. Pharmacogenomics and individualized drug therapy. Annu Rev Med 57 (2006) 119-137
23. Carmo H., Brulport M., Hermes M., Oesch F., Silva R., Ferreira L.M., et al. Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine ('Ecstasy') cytotoxicity. Pharmacogenet Genomics 16 (2006) 789-799
24. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
25. Bertilsson L., Alm C., De Las Carreras C., Widen J., Edman G., and Schalling D. Debrisoquine hydroxylation polymorphism and personality. Lancet 1 (1989) 555
26. Sindrup S.H., Poulsen L., Brosen K., Arendt-Nielson L., and Gram L.F. Are poor metabolisers of sparteine/debrissoquine less pain tolerant than extensive metabolisers?. Pain 53 (1993) 335-339
27. Gan S.H., Ismail R., Wan Adnan W.A., Zulmi W., Kumaraswamy N., and Larmie E.T. Relationship between Types A and B personality and debrisoquine hydroxylation capacity. Br J Clin Pharmacol 57 (2004) 785-789
28. Llerena A., Edman G., Cobaleda J., Benitez J., Schalling D., and Bertilsson L. Relationship between personality and debrisoquine hydroxylation capacity suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6. Acta Psychiat Scand 87 (1993) 23-28
29. Suzuki E., Kitao Y., Ono Y., Iijima Y., and Inada T. Cytochrome P450 2D6 polymorphism and character traits. Psychiat Genet 13 (2003) 111-113
30. Kirchheiner J., Lang U., Stamm T., Sander T., and Gallinat J. Association of CYP2D6 genotypes and personality traits in healthy individuals. J Clin Psychopharmacol 26 (2006) 440-442